UNITED STATES SECURITIES AND
                               EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported): June 21, 2005

                          GAMMACAN INTERNATIONAL, INC.
             (Exact name of registrant as specified in its charter)

                                    Delaware
                 (State or other jurisdiction of incorporation)

                                     0-32835
                            (Commission File Number)

                                   33-0956433
                        (IRS Employer Identification No.)

                  11 Ben Gurion St., 54100 Givat Shmuel, Israel
              (Address of principal executive offices and Zip Code)

        Registrant's telephone number, including area code: 972 3 5774475


          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))

                                      -2-


ITEM 1.01 Entry Into a Material Definitive Agreement

      On June 21, 2005, Gammacan,  Ltd., a subsidiary of Gammacan International,
Inc. (the  "Company"),  entered into an employment  agreement  with Vered Caplan
pursuant to which Ms. Caplan will serve as Chief Executive  Officer of Gammacan,
Ltd.,  effective  July 2, 2005.  Ms. Caplan was  previously  appointed as acting
Chief Executive Officer of the Company,  effective July 2, 2005. Ms. Caplan will
devote  approximately 70% of her business time to the affairs of Gammacan,  Ltd.
and the  Company.  Ms.  Caplan shall  receive a salary of $6,475 per month.  Ms.
Caplan  shall  also be  entitled  to the use of a company  vehicle,  payment  of
certain  insurance  premiums  and  payment  of 7.5% of her  salary  into a Keren
Hishtalmut Fund.  Pursuant to a separate  agreement  between the Company and Ms.
Caplan,  dated as of June 21, 2005,  the Company  agreed to indemnify Ms. Caplan
for substantially all liabilities she may incur as a result of his employment by
or service to the Company or Gammacan Ltd.

ITEM 9.01. Financial Statements and Exhibits.

10.01 Employment Agreement between Gammacan, Ltd. and Vered Caplan, dated as of
June 21, 2005

10.02 Indemnity Agreement between Gammacan International, Inc. and Vered Caplan,
dated as of June 21, 2005.

                                      -3-


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                         GAMMACAN INTERNATIONAL, INC.

                                         /s/ DAN J. GELVAN
                                         -----------------------
                                         Dan J. Gelvan,
                                         Chief Executive Officer


                                         Date: June 27, 2005